These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4344685)

  • 1. Pressinoic acid: a peptide with potent corticotrophin-releasing activity.
    Saffran M; Pearlmutter AF; Rapino E; Upton GV
    Biochem Biophys Res Commun; 1972 Nov; 49(3):748-51. PubMed ID: 4344685
    [No Abstract]   [Full Text] [Related]  

  • 2. An in vivo assay method for corticotrophin-releasing factor (CRF) in dexamethasone-nembutal treated rats.
    Itoh Z
    Endocrinol Jpn; 1966 Sep; 13(3):245-56. PubMed ID: 4291249
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of assays for corticotrophin-releasing activity.
    Chan LT; de Wied D; Saffran M
    Endocrinology; 1969 Apr; 84(4):967-72. PubMed ID: 4304035
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolated pituitary cells: CRF-like activity of neurohypophysial and related polypeptides.
    Portanova R; Sayers G
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):661-6. PubMed ID: 4352530
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACTH secretion in vitro from dispersed rat pars intermedia cells].
    Kraicer J; Dhariwal AP
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(7):935-8. PubMed ID: 4368062
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by cortisol of ACTH release from anterior pituitary tissue in vitro.
    Pollock JJ; LaBella FS
    Can J Physiol Pharmacol; 1966 Jul; 44(4):549-56. PubMed ID: 4290781
    [No Abstract]   [Full Text] [Related]  

  • 7. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin.
    Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of ACTH activity of the hypophysis through quantitative determination of adrenal gland ascorbic acid using paper chromatography].
    Binnewies SM
    Int Arch Arbeitsmed; 1972; 30(2):125-34. PubMed ID: 4343524
    [No Abstract]   [Full Text] [Related]  

  • 10. Site of the inhibiting action of diphenylhydantoin on the release of corticotrophin in epileptic patients.
    Rinne UK
    Med Pharmacol Exp Int J Exp Med; 1967; 17(5):409-16. PubMed ID: 4299898
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased adrenal sensitivity to ACTH in the vasopressin-deficient (Brattleboro) rat.
    Wiley MK; Pearlmutter AF; Miller RE
    Neuroendocrinology; 1974; 14(5):257-70. PubMed ID: 4368017
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition by cysteamine of steroid 11 -hydroxylation.
    Flemming K; Geierhass B; Seydewitz V
    Biochem Pharmacol; 1973 May; 22(10):1241-5. PubMed ID: 4350555
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipolytic activity of rat pituitaries in vitro.
    Lis M; Gilardeau C; Chrétien M
    Horm Metab Res; 1973 Jul; 5(4):253-8. PubMed ID: 4354388
    [No Abstract]   [Full Text] [Related]  

  • 14. Site of action of vasopressin in causing corticotropin release.
    Hedge GA; Yates MB; Marcus R; Yates FE
    Endocrinology; 1966 Aug; 79(2):328-40. PubMed ID: 4288429
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium, corticosterone, and adrenocorticotropic hormone release in vitro.
    Kraicer J; Milligan JV; Gosbee JL; Conrad RG; Branson CM
    Science; 1969 Apr; 164(3878):426. PubMed ID: 4304953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosterone suppression of ACTH secretion: actinomycin D sensitive and insensitive components of the response.
    Portanova R; Sayers G
    Biochem Biophys Res Commun; 1974 Feb; 56(4):928-33. PubMed ID: 4363642
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of lycorine on the pituitary-adrenal system].
    Ch'en MC; Jin SC; Wang YC
    Yao Xue Xue Bao; 1965 Dec; 12(12):767-71. PubMed ID: 4286723
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the mechanism of ACTH-secretion with special reference to the bioassay of C.R.F. in vitro].
    Nakai Y
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):957-76. PubMed ID: 4298016
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the mechanism of vasopressin in causing corticotropin release?
    Franzén G
    Endokrinologie; 1971 Apr; 57(3):338-42. PubMed ID: 4325993
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACTH and corticoid therapy].
    Policlinico Prat; 1966 Aug; 73(31):1046-9. PubMed ID: 4295392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.